Abstract
This phase 2 randomized study evaluated trebananib (AMG 386), a peptide-Fc fusion protein that inhibits angiogenesis by neutralizing the interaction of angiopoietin-1 and -2 with Tie2, in combination with paclitaxel with or without bevacizumab in previously untreated patients with HER2-negative locally recurrent/metastatic breast cancer. Patients received paclitaxel 90 mg/m(2) once weekly (3-weeks-on/1-week-off) and were randomly assigned 1:1:1:1 to also receive blinded bevacizumab 10 mg/kg once every 2 weeks plus either trebananib 10 mg/kg once weekly (Arm A) or 3 mg/kg once weekly (Arm B), or placebo (Arm C); or open-label trebananib 10 mg/kg once a week (Arm D). Progression-free survival was the primary endpoint. In total, 228 patients were randomized. Median estimated progression-free survival for Arms A, B, C, and D was 11.3, 9.2, 12.2, and 10 months, respectively. Hazard ratios (95% CI) for Arms A, B, and D versus Arm C were 0.98 (0.61-1.59), 1.12 (0.70-1.80), and 1.28 (0.79-2.09), respectively. The objective response rate was 71% in Arm A, 51% in Arm B, 60% in Arm C, and 46% in Arm D. The incidence of grade 3/4/5 adverse events was 71/9/4%, 61/14/5%, 62/16/3%, and 52/4/7% in Arms A/B/C/D. In Arm D, median progression-fre...Continue Reading
References
May 6, 2003·Circulation Research·Georgina CollettAnn E Canfield
Nov 16, 2004·Cancer Cell·Jonathan OlinerRichard Kendall
Nov 14, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ferry A L M Eskens, Jaap Verweij
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Jun 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstLee S Rosen
Mar 4, 2010·Cancer Research·Hiroya HashizumeDonald M McDonald
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W MilesGilles Romieu
May 27, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alain C MitaPatricia LoRusso
Oct 13, 2010·Molecular Cancer Therapeutics·Angela CoxonJonathan D Oliner
Mar 25, 2011·The Lancet Oncology·Miguel MartinUNKNOWN TRIO 010 investigators
Apr 13, 2011·Trends in Molecular Medicine·Pipsa SaharinenKari Alitalo
May 17, 2011·Clinical Breast Cancer·Nicholas J RobertJohn Davis
Jun 29, 2011·The New England Journal of Medicine·Daniel CarpenterSteven Joffe
Jun 29, 2011·The New England Journal of Medicine·Ralph B D'Agostino
Jun 29, 2011·Journal of the National Cancer Institute·Manish R SharmaMark J Ratain
Jul 5, 2011·Clinical Breast Cancer·Adam BrufskyJohn Hainsworth
Dec 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Beth Y KarlanIgnace B Vergote
Jan 3, 2012·Cancer Chemotherapy and Pharmacology·Jian-Feng LuYu-Nien Sun
Oct 31, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M M EatockG Bodoky
Jun 10, 2014·Cancer Treatment Reviews·Iben KümlerDorte Lisbet Nielsen
Jun 22, 2014·The Lancet Oncology·Bradley J MonkAmit M Oza
Citations
Apr 7, 2016·Critical Reviews in Biotechnology·Saman SoleimanpourS A R Rezaee
Sep 14, 2016·Oncoimmunology·Joanna StachuraAngelika Muchowicz
Jun 18, 2016·Cell Proliferation·Mei LiuZhifei Wang
Nov 15, 2016·Scientific Reports·Florence T H WuRobert S Kerbel
Jan 31, 2017·Expert Opinion on Biological Therapy·Valentina ZamboninEmilio Bria
Dec 22, 2017·Cancer·David A ReardonPatrick Y Wen
Sep 28, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sander LefereLindsey Devisscher
Feb 27, 2019·Current Oncology Reports·Jessica GillenKathleen Moore
Jul 26, 2019·BMC Cancer·Leena TiainenPirkko-Liisa Kellokumpu-Lehtinen
Nov 26, 2019·Neuro-oncology·Maren CamHakan Cam
Nov 7, 2019·Pharmacotherapy·Lei DongZhong-Ning Zhu
Feb 1, 2019·Oncotarget·Roberto Carmagnani PestanaAhmed Kaseb
Sep 2, 2020·The Journal of Clinical Investigation·Ellen C de HeerAdrian L Harris
Dec 22, 2017·Biopolymers·Marco CavacoVera Neves
May 19, 2018·Oncotarget·Sophia MagkoutaIoannis Kalomenidis
Jan 19, 2019·Oncology Letters·Lan LanHongmei Tang
Mar 7, 2020·BMC Cancer·Zhengwu SunYalin Xi
Jan 8, 2017·Breast Cancer Research and Treatment·Rajesh RamanathanKazuaki Takabe
Jul 29, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarah E S LearySusan Blaney
Dec 9, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Manuel HidalgoOliver Krieter
Jun 3, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew R Chin, Shizhen Emily Wang
Nov 30, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniela F Quail, Johanna A Joyce
Mar 21, 2021·European Journal of Pharmacology·Digna Parmar, Madhavi Apte
Apr 4, 2021·Cancers·Tomohiro FujiwaraToshifumi Ozaki
Jun 15, 2021·EMBO Molecular Medicine·Kabir A KhanRobert S Kerbel